Nestle India shares fell after the FSSAI launched three adjudication cases over baby formula marketing violations and sub-standard Biotin levels.

Dabur India has approached the Delhi High Court to challenge an FSSAI ban on its '100%' purity claims, arguing the directive unfairly benefits competitors and threatens product lines worth over Rs 150 crore.